Lin‐Pierre Zhao
Délégation Paris 5(FR)Inserm(FR)Inserm(FR)Dalian Medical University(CN)Université Paris Cité(FR)Saint Louis University Hospital(US)Sorbonne Paris Cité(FR)Acute Leukemia French Association(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Second Affiliated Hospital of Dalian Medical University(CN)Linyi City Chinese Medicine Hospital(CN)Centre de Recherche Saint-Antoine(FR)First Affiliated Hospital of Dalian Medical University(CN)Institut Cochin(FR)Hôpital Saint-Louis(FR)
Publications by Year
Research Areas
Otitis Media and Relapsing Polychondritis, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*(2021)389 cited
- → Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes(2023)104 cited
- → A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML(2022)86 cited
- → Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases(2022)64 cited
- → Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX(2024)56 cited
- → Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease(2021)52 cited